Comparison of Six-Month Outcomes for Primary Percutaneous Revascularization for Acute Myocardial Infarction With Drug-Eluting Versus Bare Metal Stents (from the APEX-AMI Study)

American Journal of Cardiology

Volumn 103, Issue 2, 2009, Pages 181-186

  Patel, Manesh R ^a   Pfisterer, Matthias E ^b   Betriu, Amadeo ^c   Widmisky, Petr ^d   Holmes Jr , David R ^e   O'Neill, William W ^f   Stebbins, Amanda ^a   Van de Werf, Frans ^g   Armstrong, Paul W ^h   Granger, Christopher B ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HOSPITAL CLÍNIC   (Spain)

^d CHARLES UNIVERSITY   (Czech Republic)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IIB IIIA INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEXELIZUMAB; PLACEBO; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HAZARD RATIO; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REVASCULARIZATION; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; DATA INTERPRETATION, STATISTICAL; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; RECURRENCE; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 58149471355     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.066     Document Type: Article

References (27)

1. Laarman G.J., Suttorp M.J., Dirksen M.T., van Heerebeek L., Kiemeneij F., Slagboom T., van der Wieken L.R., Tijssen J.G.P., Rensing B.J., and Patterson M. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
2. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrie D., Slama M.S., Merkely B., Erglis A., Margheri M., et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
3. Kernis S., Cohen D., Reid K., Bach R., Messenger J., Krumholz H., Rumsfeld J., Curtis J., Peterson E., and Spertus J. Clinical outcomes associated with the use of drug-eluting stents compared with bare metal stents for primary percutaneous intervention. Am J Cardiol 96 suppl (2005) 47
4. Daemen J., Wenaweser P., Tsuchida K., Abrecht L., Vaina S., Morger C., Kukreja N., Juni P., Sianos G., Hellige G., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
5. Investigators A.A., Armstrong P.W., Granger C.B., Adams P.X., Hamm C., Holmes Jr. D., O'Neill W.W., Todaro T.G., Vahanian A., and Van de Werf F. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA 297 (2007) 43-51
6. Stebbins A.L., Lee K., Armstrong P.W., Hamm C., Van De Werf F., James S., Toftegaard Nielsen T., Seabra-Gomes R., White H.D., and Granger C.B. A new model for predicting mortality in acute ST elevation myocardial infarction treated with primary PCI: results from the APEX AMI trial. Eur Heart J 28 suppl (2007) 59
7. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
8. Antoniucci D., Santoro G.M., Bolognese L., Valenti R., Trapani M., and Fazzini P.F. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 31 (1998) 1234-1239
9. Rodriguez A., Bernardi V., Fernandez M., Mauvecin C., Ayala F., Santaera O., Martinez J., Mele E., Roubin G.S., Palacios I., and Ambrose J.A. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. Am J Cardiol 81 (1998) 1286-1291
10. Grines C.L., Cox D.A., Stone G.W., Garcia E., Mattos L.A., Giambartolomei A., Brodie B.R., Madonna O., Eijgelshoven M., Lansky A.J., O'Neill W.W., and Morice M.C. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341 (1999) 1949-1956
11. Saito S., Hosokawa G., Tanaka S., Nakamura S., and PASTA Trial Investigators. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. Catheter Cardiovasc Interv 48 (1999) 262-268
12. Maillard L., Hamon M., Khalife K., Steg P.G., Beygui F., Guermonprez J.L., Spaulding C.M., Boulenc J.M., Lipiecki J., Lafont A., et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol 35 (2000) 1729-1736
13. Zhu M.M., Feit A., Chadow H., Alam M., Kwan T., and Clark L.T. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 88 (2001) 297-301
14. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.-C., Colombo A., Schampaert E., Grube E., Kirtane A.J., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
15. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
16. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M.J., Baumgart D., et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
17. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and Investigators B.-L. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
18. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
19. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., Wallentin L., and Group S.S. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
20. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and Investigators E.R. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
21. Maisel W.H. Unanswered questions-drug-eluting stents and the risk of late thrombosis. N Engl J Med 356 (2007) 981-984
22. Van de Werf F. Drug-eluting stents in acute myocardial infarction. N Engl J Med 355 (2006) 1169-1170
23. Harrington R.A., and Ohman E.M. The enigma of drug-eluting stents: hope, hype, humility, and advancing patient care. JAMA 297 (2007) 2028-2030
24. Menichelli M., Parma A., Pucci E., Fiorilli R., De Felice F., Nazzaro M., Giulivi A., Alborino D., Azzellino A., and Violini R. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol 49 (2007) 1924-1930
25. Newell M.C., Henry C.R., Sigakis C.J.G., Unger B.T., Larson D.M., Chavez I.J., Burke M.N., Traverse J.H., and Henry T.D. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97 (2006) 1299-1302
26. Valgimigli M., Percoco G., Malagutti P., Campo G., Ferrari F., Barbieri D., Cicchitelli G., McFadden E.P., Merlini F., Ansani L., et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 293 (2005) 2109-2117
27. Pasceri V., Patti G., Speciale G., Pristipino C., Richichi G., and Di Sciascio G. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J 153 (2007) 749-754